Atopic dermatitis management: comparing the treatment patterns of dermatologists in Japan, USA and UK

被引:19
作者
Baron, ED
Barzilai, D
Johnston, G
Kawashima, M
Takigawa, M
Nakagawa, H
Graham-Brown, RAC
Stevens, SR [1 ]
机构
[1] Univ Hosp Cleveland, Res Inst, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Cleveland, OH 44106 USA
[3] VA Med Serv, Cleveland, OH USA
[4] Epidemiol & Biostat, Cleveland, OH USA
[5] Leicester Royal Infirm, Leicester, Leics, England
[6] Tokyo Womens Med Univ, Tokyo, Japan
[7] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka 43131, Japan
[8] Jichi Med Sch, Minami Kawachi, Tochigi 32904, Japan
关键词
atopic dermatitis; treatment variation;
D O I
10.1046/j.1365-2133.2002.04895.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background The incidence of atopic dermatitis (AD) is increasing worldwide. No large-scale study has previously compared the therapeutic management of this condition in different countries. Objectives The purpose of this study was to determine the treatment preferences of dermatologists in Japan, the U.S.A. and the U.K., and investigate their relationship with certain factors pertaining to the physician and his practice. Methods A questionnaire was sent to all registered members of dermatological societies in Japan, the U.S.A. and the U.K. Responses were collated and statistical analysis performed using chi(2) , Mantel-Haenszel and Breslow heterogeneity tests. Results Three thousand six hundred and eighty-eight completed surveys were returned. U.S.A. and U.K. physicians were significantly more aggressive in prescribing systemic medications, such as steroids, antibiotics and immunosuppressants, compared with those in Japan. Japanese dermatologists also utilized topical steroids significantly less. The use of alternative remedies was highest in Japan. All three countries had a relatively high degree of optimism for topical immunosuppressants, but less so for other emerging therapies. Conclusions Both similarities and differences in the therapy of AD exist in the three countries studied. Factors related to the physician, patient population and culture may influence these observations.
引用
收藏
页码:710 / 715
页数:6
相关论文
共 22 条
[1]  
Barker Jonathan N. W. N., 1998, Journal of Dermatology (Tokyo), V25, P818
[2]   The prevalence and incidence of atopic dermatitis in a birth cohort: The importance of a family history of atopy [J].
Bleiker, TO ;
Shahidullah, H ;
Dutton, E ;
Graham-Brown, RAC .
ARCHIVES OF DERMATOLOGY, 2000, 136 (02) :274-274
[3]   CYCLOSPORINE-A IN SEVERE, THERAPY-RESISTANT ATOPIC-DERMATITIS - REPORT OF AN INTERNATIONAL WORKSHOP, APRIL 1993 [J].
CAMP, RDR ;
REITAMO, S ;
FRIEDMANN, PS ;
HO, V ;
HEULE, F .
BRITISH JOURNAL OF DERMATOLOGY, 1993, 129 (02) :217-220
[4]   Topical corticosteroid phobia in patients with atopic eczema [J].
Charman, CR ;
Morris, AD ;
Williams, HC .
BRITISH JOURNAL OF DERMATOLOGY, 2000, 142 (05) :931-936
[5]  
Eaglstein William H., 1998, Journal of Dermatology (Tokyo), V25, P823
[6]  
Emerson RM, 1998, BRIT J DERMATOL, V139, P73
[7]   The epidemiology and experience of atopic eczema during childhood: a discussion paper on the implications of current knowledge for health care, public health policy and research [J].
Fennessy, M ;
Coupland, S ;
Popay, J ;
Naysmith, K .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2000, 54 (08) :581-589
[8]  
Graham-Brown R. A. C., 2000, Journal of Investigative Dermatology, V114, P775
[9]  
Herd RM, 1996, BRIT J DERMATOL, V135, P18
[10]  
Herd RM, 1996, BRIT J DERMATOL, V135, P20